Success Stories: No RFE, Fast Approval: NAILG Secured EB-1A for Leading Researcher in Human Liver Disease

Client’s Testimonial:

“I wanted to take a moment to sincerely thank you for your exceptional support and guidance throughout the I-140 EB1A petition process. I am thrilled to know that the petition has been approved, and I truly could not have reached this milestone without your expertise, diligence, and encouragement. Your deep knowledge of the process, meticulous attention to detail, and unwavering commitment to presenting the strongest possible case were evident every step of the way. I greatly appreciate the time you invested in understanding my background and helping to frame my qualifications effectively.”

On May 29^th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Appointee in the Field of Human Liver Disease (Approval Notice).

General Field: Human Liver Disease

Position at the Time of Case Filing: Postdoctoral Appointee

Country of Origin: Nepal

State of Residence at the Time of Filing: Indiana

Approval Notice Date: May 29^th, 2025

Processing Time: 16 days (Premium Processing Requested)

Case Summary:

Our client has emerged as a leading voice in the field of liver disease, particularly through his groundbreaking work on nonalcoholic fatty liver disease (NAFLD), liver regeneration, and gene regulation. His investigations have yielded original discoveries and novel approaches that have reshaped the understanding of disease mechanisms and therapeutic options. His research addresses one of the world’s most urgent health crises: the rapidly increasing prevalence of chronic liver disease.

Scientific Contributions with Global Reach

His work has led to several high-impact discoveries, including insights into apoptosis in liver cancer, miRNA regulation in NAFLD, and the influence of sex and aging in MASLD. These contributions offer important avenues for targeted therapy and public health intervention. One expert emphasized his impact in their exact words:

“His approach to medicine is also a feasible complementary treatment option for fighting viral infections like HBV, which helps to improve the efficacy of conventional treatments and increase precision medicine. Since cancer is the leading cause of mortality in the U.S., combating its prevalence is of utmost concern for the healthcare system. [Client]’s work must continue uninterrupted to benefit public health and strengthen the nation’s healthcare system.”

Recognized by Peers and Institutions Alike

His work has earned research support from prestigious institutions, including the Department of Science and Technology and the Department of Biotechnology of the Government of India, as well as the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), highlighting both its international recognition and alignment with U.S. healthcare priorities.

His publication record includes 14 peer-reviewed journal articles (3 first-authored) and 6 abstracts (1 first-authored), with 353 citations by researchers across at least 38 countries. He has also completed 26 journal peer reviews, reflecting his standing in the scientific community.

Seamless Approval with NAILG’s Strategic Expertise

When pursuing the EB-1A petition, our client partnered with the North America Immigration Law Group (NAILG), which built a compelling case demonstrating his extraordinary ability. NAILG emphasized not only his scientific productivity but also the direct relevance of his research to critical U.S. healthcare challenges, particularly those related to liver disease, metabolic dysfunction, and precision medicine.

Approved in Just 16 Days, No RFE

The petition was approved in only 16 days under Premium Processing, with no Request for Evidence (RFE). This swift and seamless approval reflects both the strength of our client’s qualifications and the effectiveness of NAILG’s legal strategy. He is now positioned to continue making high-impact contributions to biomedical research in the United States.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.